The University of Missouri Research Reactor (MURR) has joined Nuclear Medicine Europe, the leading industry association for the radiopharmaceutical and molecular imaging industry in Europe. This partnership allows MURR to contribute more effectively to the global nuclear medicine community and collaborate with European institutions and companies on research, production, and application of radiopharmaceuticals. MURR's expertise and resources will be a valuable addition to the association's efforts in advancing nuclear medicine and improving patient outcomes. Mizzou's membership in Nuclear Medicine Europe will be supported by NextGen MURR, a new state-of-the-art research reactor being built in Columbia. This association is an important step towards ensuring a sustainable global supply of lifesaving medical treatments.
Wed, 17 Jul 2024 12:01:54 GMT | University of Missouri